Oramed Pharmaceuticals, Inc.  

(Public, NASDAQ:ORMP)   Watch this stock  
Find more results for ORMP
6.12
-0.09 (-1.45%)
Feb 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.01 - 6.24
52 week 5.70 - 10.51
Open 6.22
Vol / Avg. 22,113.00/21,519.00
Mkt cap 80.50M
P/E     -
Div/yield     -
EPS -0.86
Shares 13.28M
Beta 0.76
Inst. own 10%

Key stats and ratios

Q4 (Nov '16) 2016
Net profit margin -432.13% -1710.45%
Operating margin -393.11% -1561.62%
EBITD margin - -1561.00%
Return on average assets -24.10% -31.70%
Return on average equity -42.14% -42.98%
Employees 12 -
CDP Score - -

Address

Hi-Tech Park 2 4 Givat Ram, PO Box 39098
JERUSALEM, 91390
Israel
+972-2-5660001 (Phone)
+972-2-5660004 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Oramed Pharmaceuticals Inc. (Oramed) is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed’s flagship product, an orally ingestible insulin capsule in phase II clinical trials, is focused on the treatment of diabetes. The Company is developing orally ingestible protein oral delivery (POD) technology for the delivery of drugs presently administered by way of injection. Oramed’s delivery platform protects protein sand enhances their absorption, allowing them to reach the blood stream through the portal vein. The Company’s products include ORMD-0801, Oral insulin capsule; ORMD 0901, Oral Exenatide capsule; and combination therapy of ORMD 0801 + ORMD 0901. ORMD-0801 is under phase II A clinical trials. ORMD-0901 is under preclinical/Investigational New Drug (IND) stage under phase I B.

Officers and directors

Nadav Kidron President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Yifat Hen Zommer Chief Financial Officer, Treasurer, Secretary
Age: 39
Bio & Compensation  - Reuters
Joshua Hexter Chief Operating Officer, Vice President - Business Development
Age: 43
Bio & Compensation  - Reuters
Miriam Kidron Ph.D. Chief Medical and Technology Officer, Director
Age: 72
Bio & Compensation  - Reuters
Xiaopeng Li Director
Age: 31
Bio & Compensation  - Reuters
Michael Berelowitz Independent Director
Age: 70
Bio & Compensation  - Reuters
Harold Jacob M.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
Gerald M. Ostrov Independent Director
Age: 65
Bio & Compensation  - Reuters
Leonard Sank Independent Director
Age: 48
Bio & Compensation  - Reuters